London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Started: unhooked, 17 Apr 2023 11:02
Last post: unhooked, 25 Apr 2023 11:08
It does seem the board is finally waking up to the dire situation here. Laying down a pathway to possible wind-up in 2 years time is not tinkering around the edges. Market reaction's been positive too.
What an absolutely disastrous investment this has been.
I sold out at 95 or thereabouts when it was WPCT and there were plenty of us giving warnings about this stupidly over-valued share. LTH's have my full sympathy.
We have a change of name, change of valuer, change of registrar, change of auditor, change to the articles, a change to the board (but they can't find a NED replacement so they're paying headhunters to find one) and, finally, a continuation vote in 2025.
Re the continuation vote: it will provide shareholders with the opportunity to vote on whether the Company "should continue in its present form". What does that mean ? That the company might continue in a different form? Or a straightforward wind-up with all assets sold for cash and returned to shareholders? In the case of the latter, does anyone really think we'll get the NAV?
Re the buybacks: I say, with what money? The total value of all buybacks over the past 2 years, per the chairman's statement, amounts to a paltry one million quid. Peanuts.
I've only read the chairman's statement so far. That's as much as i can take on a Monday morning.
Started: pasajerodeltoro, 21 Apr 2023 11:15
Last post: pasajerodeltoro, 21 Apr 2023 11:20
TICKER TIDM: INOV
https://investing.thisismoney.co.uk/rns/news/33449724
"SCHRODERS CAPITAL GLOBAL INNOVATION TRUST PLC
(formerly Schroder UK Public Private Trust plc)
(the 'Company')
CHANGE OF NAME
Legal Entity Identifier: 2138008X94M7OVE73177
The Board is pleased to announce that, as stated in the Report and Accounts for the year ended 31 December 2022, in order to better reflect the Company's current investment objective, the Company has today changed its name to Schroders Capital Global Innovation Trust plc. The London Stock Exchange stock ticker symbol (TIDM) will also change from SUPP to INOV with effect from 8.00am on 21 April 2023. The Company's ISIN, SEDOL, and LEI remain unchanged.
The Company's website address will shortly be renamed www.schroders.com/inov
20 April 2023"
Started: Scarfell, 12 Apr 2023 20:22
Last post: Scarfell, 12 Apr 2023 20:22
The running of this fund into the ground has made me determined not to ever invest in any Schroder fund again.
Started: unhooked, 21 Mar 2023 10:25
Last post: 404x, 21 Mar 2023 10:54
It's a funny investment whereby the most profitable option would be for them to simply sell everything and shut the doors. By continuing to run the fund, they are effectively eroding value.
That assumes their NAV can be trusted of course. Discount certainly reflects a big dose of scepticism for the value they place on their unlisted stocks. It doesn't help that there's such a long gap between them updating the NAV for those. September 30th last year feels like an ice ago with all that's happened in the markets. One thing's certain, things haven't improved since then.
Discount to NAV approaching the all-time record of 60%, which it reached in Feb 2020.
Jeez, what an underperformer!
Started: pasajerodeltoro, 13 Mar 2023 14:03
Last post: pasajerodeltoro, 15 Mar 2023 14:08
Is El Salvador Still Dangerous? I Went To Find Out | Sabbatical
https://youtu.be/bKLnMSvbBmk
Might be a good idea to invest in El Salvador...
...or at least visit the place and copy what they are doing.
Another good idea, bearing in mind recent extreme food inflation.
Use waste heat from server farms in greenhouses:
https://www.datacenterdynamics.com/en/analysis/server-farms-serving-farms-data-centers-and-indoor-farming/
Should the management of Schroder's and this trust decide to hold a crypto reserve of some sort...
PROCEED WITH CAUTION!! Even Max Keiser is warning people about crypto-frauds.
https://twitter.com/maxkeiser/status/1633537532989153280?s=20
Might be best to invest in server farms that can be used as crypto-mining rigs,
rather than relying on day or swing-trading cryptocoins.
Server farms can also have a valuable by-product: heating.
https://www.greenbuildingadvisor.com/article/using-server-farms-to-heat-buildings
- As I recall, Woodford invested in a heating company that involved cold fusion or something like that.
- With these server-farms, you will get real heat using real assets and real science, rather than pseudoscience.
5. If they manage to get enough profit over a year,
advertize that they will pay out a dividend if they can pay out higher than a 1 year govt bond yield.
- If average investors see 5% dividend being offered by SUPP whilst the base rate is 4%, which will go for?
A couple of TR1s yesterday.
Blackrock halved their holding from 9.3% to 'Below 5%' and City of London Investment Management upped their holding from 11% to 16%. Presume one sold to the other.
What does it all mean? No idea, probably nothing.
Started: ripley94, 22 Jan 2023 17:39
Last post: unhooked, 2 Feb 2023 10:29
Cheers ripley, I do my best although I often feel like I'm flailing in the dark!
Interesting times over at BWNG..
Thankyou unhooked , Just noticed your comments after posting on BWNG board .
You appear to be a genuine poster .
The whole history leaves a bad feeling that the Schroder Juniors are treading water with this trust - happy managing the decline and picking up the juicy 1% management fee (based on the NAV, not market cap, note), and with no performance fee. One thing I loved about the old WPCT was that it was paid 100% out of performance fees… with a 10% p.a. hurdle.
It’s going to take a lot to turn SUPP around. Only ‘loss aversion’ (or the sunk cost fallacy or whatever they call it) – something I’m badly afflicted with – keeps me from getting out at what would be a big loss.
Here’s my tuppence worth. The 3 Woodford entities were Woodford Equity Income Fund , Woodford Income Focus Fund and the forerunner of this trust, WPCT. Sadly, I've been in all 3 at various times. The Income Focus fund concentrated almost exclusively on large cap income payers and I don't think it had any holdings in common with the trust. The Equity Income Fund, his main entity, did have holdings in common: before the fund's demise, in an effort to improve liquidity in the face or redemptions, Woodford pulled off a stunt whereby he packaged up most of the fund's holdings in common with the trust (the illiquid ones), and 'sold' them to the trust in return for shares in the trust. The result was that the trust doubled up on a number of esoteric holdings, including a load of really dodgy stuff, and also ended up with an overhang of its shares as the fund set about selling the newly 'acquired' shares. I remember this financial engineering by Woodford to save his back caused a lot of disquiet among investors in the trust. The stunt didn't ultimately work for the fund either because, as we all know, Kent County Council shortly came in with a redemption request for £230m worth of units and that was that. The point is, I don't think there were many (or any) holdings in common left when Link set about liquidating the main fund... and if they were, I'd have thought they'd have been long sold off by now... unless you know different Agricore? Certainly, Link didn't try to sell them to SUPP (like Woodford had to WPCT).
So, in terms of what's depressing the NAV or causing the persistent discount, I don’t think it’s the overhang of stocks in common which Link are trying to sell, because I don't think it exists anymore. For me, the reasons are to do with lingering doubts over the quality of the Woodford legacy portfolio along with growing doubts about Schroders after 3 years in charge. To underline my point about Schroders, the 1st thing they did, to reduce the trust's debt, was sell some good quality biotechs to a specialist healthcare investor who quickly sold them on for double or triple what they paid us. That didn't help sentiment. Then, their first stock pick was JMT, which I remember they lauded pompously in some blurb as a world beating UK disruptor, etc, etc, and then it promptly crashed 30% following a profit warning or news they were getting out of batteries or some such. That also didn't help sentiment! Actually, have any of their picks done well? More recently we've had the appalling 'administrative error' in the valuation of Benevolent AI in the books of SUPP, which knocked a few pence off the NAV, and which caused Schroders to sack Link and bring valuations in-house. I don't know about you all, but somehow that didn't fill me with confidence (neither the mistake itself, nor the bringing of valuations in-house).
I think a large reason for the ongoing depression and substantial discount here is that Woodford's Equity Income Fund and Patient Capital Fund (I remember there were 3 in total including what is now SUPP) have holdings in common so Link are under pressure to liquidate and return money to the other 2 funds. If you look at Benevolent AI for example this is noted under the "news" articles there.
SUPP, meanwhile, is faced with ongoing selling pressure almost despite how the companies are doing. We know ONT is not doing great but other holdings like Atom Bank, Reaction Engines are actually real gems. I'm happy to hold here because the selling will end during 2023 (the new article talks to mid 2023). To sell out in depressed markets wouldn't be a smart move.
.....When Woodford called it Patient Capital, he wasn't kidding.
Started: pasajerodeltoro, 21 Dec 2022 18:48
Last post: pasajerodeltoro, 21 Dec 2022 18:48
Probably a prudent move considering all the vaccine damage lawsuits...
Good to invest in fixing the damage done by some unscrupulous big-pharma companies, NGOs and government s!
Started: pasajerodeltoro, 16 Nov 2022 17:04
Last post: pasajerodeltoro, 16 Nov 2022 17:04
Started: pasajerodeltoro, 2 Nov 2022 10:04
Last post: unhooked, 8 Nov 2022 22:29
Yup, there wasn't much competition when Schroders took over management of the Trust from W.I.M., as the portfolio was viewed as a bit of a poisoned chalice at the time. In the 3 years since, all they seem to have done is manage the decline. If they're learning on the job, they are certainly getting well paid for it.
Must be fair though and acknowledge that these are not the best of times to be investing in pre-profitable private companies, as the performance of any number of 'growthy' private equity investment trusts would testify.
Make of this what you will, but this name pops up in management:
"William Heathcoat Amory"
When Looked that up, I got this:
https://en.wikipedia.org/wiki/Heathcoat-Amory_baronets
One of their worst pieces of work I think.
In all those pages of analysis, how can they not even mention the name Woodford and his legacy on SUPP and its portfolio? If you buy SUPP today, and into the foreseeable medium term, you are substantially taking a bet on the Woodford picks. Doesn't get a mention. History blanked and re-written!
Likewise no mention of the truly appalling worst-in-class performance over 5 years. Rather it's all lame excuses about the Schroder Juniors and how we must give them more time. They've had 3 years and have done nothing to improve the performance or the shocking discount... and that's mostly down to the Woodford picks, but no mention again.
History blanked and re-written!
As a LTH, I agree with one thing: One day - eventually - this trust will begin to do better - it can hardly do worse can it? - but in the meantime, prepare for many, many more grey hairs.
As for the authors, Trust Intelligence, I admit to using them when researching other investment trusts, but such one-sided writing is a joke!
"Sell side" marketing at its worst!
Looks like they are beginning to build up a profile of SUPP here.
https://www.trustintelligence.co.uk/investor/articles/fund-research-investor-schroder-uk-public-private-retail-oct-2022#summary
Started: theoldmansdoneit, 24 Oct 2022 16:50
Last post: pasajerodeltoro, 28 Oct 2022 14:20
Check the support and resistance levels on the chart settings, go through the previous results, check the status of the quoted companies that they still have stakes in, and if you are happy with that you can average down at these low levels. However Sunak lied about fracking so don't be to hopeful. For all you know he's there to liquidate the UK and flog it to BlackRock like the Woodford fund was. You probably won't make a profit until he his gone , and maybe the Tory Party too. Only viable alternative that I see is Reform UK atm, so check them out.
Hello Sir
I need help. I am badly stuck in the share. I need advice. Should I buy at this price or only just hold what I have. My average price is £0.40p
Many thanks
The ex income NAV is 31.51 but the cum (with) income NAV is 31.21. How is it that by including income it reduces the NAV. This doesn’t make sense to me. Can anyone explain please?
Either way, the discount to NAV continues to be massive and so share buybacks should hopefully prove to be profitable in the long run.
Started: Wolf12345, 18 Oct 2022 14:52
Last post: unhooked, 24 Oct 2022 18:59
Yup, the Schroder Juniors sold Kymab and a couple of others, soon after they took over management. They were desperate for liquidity.
Don't think there'll be much in the way of buy-backs, the Schroder Juniors have said they want to prioritise funding for follow-on investments/cash calls on their yet-to-be-profitable holdings.
They need some proper advisors, I think.
If I'm reading this right, they missed a big payday there.
"The clearest indication of what a company is worth is
ultimately what someone is prepared to pay to own it outright.
A recent example would be Kymab, which was a privatecompany held within
Schroder UK Public Private Trust (SUPP).
It develops monoclonal antibody therapeutics for use in
oncology and immune disorders amongst other indications;
technology that is transformative for medicine. It was recently
purchased outright by the global pharmaceutical company,
Sanofi, for up to $1.5bn ; which is a price per share 4x the level
of where it had been formally valued within SUPP."
Momentum Global Investment Management Ltd. +44.61m / +3,485.47% 45.89m
- Here's their South Africa n website: https://momentum.co.za/momentum/invest-and-save
Look under Institutional shareholders on the following webpage - you need to scroll down the page
https://markets.ft.com/data/investment-trust/tearsheet/profile?s=SUPP:LSE
Started: Wolf12345, 18 Oct 2022 14:54
Last post: Wolf12345, 18 Oct 2022 14:54
Scroll down the page on see the latest presentation by Schroder on SUPP.
https://www.schroders.com/en-gb/uk/individual/funds-and-strategies/investment-trusts/schroder-uk-public-private-trust-plc/?&utm_source=bing&utm_medium=cpc&utm_campaign=Investment%20Trusts%20-%20Public%20Private%20Trust%20-%20Exact&utm_term=schroder%20uk%20public%20private%20trust%20plc&utm_content=Brand&gclid=a5ce7bec9f661f56302b18a23ed94a62&gclsrc=3p.ds
Started: Agricore, 6 Jun 2022 08:41
Last post: unhooked, 4 Oct 2022 20:09
Sad to read of the difficulties for staff, but I'm afraid the truth was that Rutherford could not turn itself into a viable, sustaining business and so could not continue forever. Something had to give and from the narrow perspective of this trust, it's a good thing that we stopped throwing good money after bad.
As the years go by, the quality of SUPP's portfolio slowly improves as the bad ones go to the wall.
Read this news from 7/ 6/22
Private healthcare provider which operates a network of cancer and diagnostic centres in the UK has gone into liquidation, leaving radiographers wondering how they will pay their bills at the end of the month.
Rutherford Health Group has a network of oncology centres known as the Rutherford Cancer Centres located in South Wales, Northumberland, Liverpool and the Thames Valley.
More recently the Group opened the first community diagnostics centre of its kind in England.
Staff at the Group’s centres were informed today and arrangements are being made to transfer patients to alternative facilities.
A radiographer who wished to remain anonymous and who has worked at the company for two years told Synergy that the news has come as a complete shock.
"We had been made aware that the latest investment attempt fell through and last week the communications were still focused on arranging that, so to come in today to liquidation was a surprise, to say the least.
"Everyone is devastated at the moment and really scared - we don't even get redundancy pay, we have to get statutory, so naturally everybody is really worried about bills etc especially as most hospitals have already finished their recruitment drives for the year.'
The source said the mood among employees was extremely negative.
"People are really angry to be honest. We had even just hired an apprentice rad a couple of months ago and nobody is having their questions answered at the moment - all the senior managers in the big Teams call this morning were acting as if we should be grateful that we have a job until Thursday, even though people have no idea how they will pay their mortgages and bills by the end of the week."
They added that many radiographers had shown considerable commitment and loyalty to Rutherford.
"Some of the rads are single parents, many have mortgages and we are just being kicked to the kerb after all we have done for this company. Really shameful way to treat employees who were so committed to the cause," they said.
The company said a number of factors have contributed to the decision including a drop in patient numbers during the pandemic.
Rutherford added that it “made efforts to increase patient flow by offering the NHS a not-for-profit national contract in addition to existing local contracts but this was not taken up”.
Sean Sullivan, chief restructuring officer and interim CEO, said: “Covid has been particularly damaging for us as fewer patients were presenting with side effects during the lockdowns, and as a result cancer diagnosis has been delayed and sadly, in many cases, missed. This has meant fewer cancer patients have been presenting to our centres.
“Added to that, the business had grown rapidly over recent years. It was a very expensive business to set up, with over £240 million of capital expenditure to build and develop the cancer centres across the country, however, unfortunately patient numbers have not matched that.
I agree Agricore, Rutherford has been a money pit for a couple of years or so, glad to see the back of it TBH.
ONT up 10% this morning alone must have erased as good chunk of the 2.5p.
The portfolio now looks leaner and more investable.
The NAV is never going to reach the current share price imo.
Time to add
Disappointing but not altogether surprising - build and they will come…. Not if the NHS aren’t buying they won’t. We should see some proceeds from the sale of the proton equipment so the final result should be less than the 2.5p reduction of NAV. Meanwhile ONT is rebounding from recent lows and JMAT is doing better. There are some exciting positions in fintech which will come good too. Just like it was for Rutherford…… more patience required!! GLA
Started: ripley94, 30 Sep 2022 19:54
Last post: ripley94, 30 Sep 2022 19:54
I see Sphere Medical was taken over by another company recently Woodford invested a lot of cash in it .
Will there be anything back for the shares held once by this fund .
Or was everything lost in administration of Sphere plc ?
Started: pasajerodeltoro, 11 Aug 2022 18:04
Last post: pasajerodeltoro, 11 Aug 2022 18:07
Seems to be a bit of a UK patriot.
Oxford Nanopore is not selling out to US offers apparently, which suggests real value in their company.
https://www.msn.com/en-gb/money/other/oxford-nanopore-boss-flies-flag-for-uk-science-after-others-sell-out/ar-AA10nIZ0?fromMaestro=true
Oxford Nanopore Technologies’ (ONT) Buy Rating Reaffirmed at Berenberg Bank
https://www.defenseworld.net/2022/08/09/oxford-nanopore-technologies-ont-buy-rating-reaffirmed-at-berenberg-bank.html
Started: NoQuestionMarks, 10 May 2022 11:20
Last post: pasajerodeltoro, 19 May 2022 20:24
Given recent events, I think they should invest in Reaction Engines and get the US State department to buy their superior hypersonic products. Best be safe than sorry.
ONT might well be dragging down the NAV but the buyback will have no effect on the NAV itself, only, theoretically, on the discount to NAV.
Seems clear they don't have much ammo (cash) for a meaningful buyback anyway.
Sorry, should have read
*How much cash they have was NOT stated*
Tim Doig said they were in a net cash position at the webinar at the end of April.
He said they had dipped into the revolving credit facility to fund investments whilst waiting for the £12m to come through for seedrs .
How much cash they have was stated however.
It can't be much, less than £9m would be my guess.
The NAV is being dragged down by Oxford Nanopore.
IPO at 425p
Rose to over 700p.
And now trading at 260p
Roger said that Schroders believe that there was some upside still on the table at the IPO price and that the company have exceeded their expectations pre IPO.
If you trust Schroders judgement the only way is up!
Wow, so they've actually commenced the buyback? With what money I wonder? Proceeds from past sales I presume, because I doubt the SUPP portfolio produces a yield... Anyway, if there is spare cash lying around, this is a better use of it than new investments I think.
Started: pasajerodeltoro, 4 Apr 2022 12:11
Last post: Agricore, 2 May 2022 22:08
The recent rebound (15%) of JMAT which SUPP bought in at just over £20 is now priced at £22. This equates to a £0.5m uplift to NAV in Tuesday's results..... about 0.25% of NAV so fairly irrelevant but it's important because it is one of Schroder's "new" investments.
Meanwhile there's been a drop of 20% of NAV since 31/12/21 (£113m) and a drop of NAV from 48p to 38p. Given the large number of biotech holdings (65% is "health" in the annual report) this is not unusual across that vertical.
Of particular note ONT suggests the remaining portfolio is performing extremely strongly. To put it in perspective the SP of ONT has dropped by around £64m since 31/12/21 so about 14% of NAV.
What's interesting is Biotech is clearly in the "despair" phase and suffering overhang from covid testing and vaccine euphoria - and anti-Cathie Wood rhetoric...... Meanwhile gene therapy and various breakthroughs are incredibly exciting and genuinely game changing. I'm very excited about what ONT will bring. So I remain positive here but recognise and acknowledge the poor sector results. However the ghost of Woodford isn't the reason this is doing poorly. The drops are less than I'm seeing elsewhere e.g. BIOG, ARIX
I think it's incredible that the NAV is still holding at 38-39p considering the doldrums that ONT finds itself in.
From memory they revalue non public traded portfolio 6 monthly so perhaps we'll see a painful revision downwards soon (or not?) and that is why this remains on a >40% discount to NAV?
I've topped up here (and on IPO) as I believe ONT has a bright future and patience will be rewarding. The cross read from IPO suggests the private portfolio could be stronger than the market perceives?
pasajero, with all respect to you, why are you posting link after link relating to the June 30th Interims? They were out months ago and we've all read them.
You're also turning this board into a bit of an echo chamber, which is a pity.
Review of 2021 Presentation and some reference links for research:
[9:36] Kymab: "Sold at £1.3bn...Original invested £8m, £1m extra increased by 9 or 10 times"
https://www.thisismoney.co.uk/money/markets/article-9135357/Cambridge-scientists-bonanza-firm-sold-815m.html
[10:41] Oxford Nanopore IPO (ONT): "Held 2bn, financing round was about 2.5bn...IPO opened at £4.25. We sold 10% ..at that price, generating about £11m proceeds for us...Post dilution, we now own 2.9%(25.9M shares) ONT...6 mth lock-up. https://www.thetimes.co.uk/article/oxford-nanopore-receives-50m-as-dispute-is-settled-9j3ghzhrq
https://www.theaic.co.uk/aic/news/citywire-news/oxford-nanopore-ipo-move-lifts-schroder-uk-public-private
Last web conference here (2021): https://schroders.wistia.com/medias/nwc9pu3gpc
"On Friday, 1 October 2021, fund managers Roger Doig and Tim Creed presented the Trust's Interim Results for the period ending 30 June 2021. The live presentation was followed by Q&A. "
Started: unhooked, 26 Apr 2022 17:16
Last post: unhooked, 26 Apr 2022 17:16
"The Company (LSE: SUPP) is pleased to announce the completion of BenevolentAI's business combination with Odyssey Acquisition S.A. ("Odyssey"), a Euronext Amsterdam-listed investment company. For further information on the transaction, investors can refer to the announcement made by the Company on 6th December 2021.
Assuming sufficient secondary market liquidity, BenevolentAI will henceforth be valued using its unadjusted quoted price which will be reflected in the Company's daily indicative unaudited NAV per share as of 25th April 2022. The valuation impact of the transaction has already been partially reflected in the Company's net asset value with the AIFM increasing the valuation of the holding from £22.4 million as at 30 September 2021 to £28.5 million as at 31 December 2021. It is anticipated that the value of the Company's holding as of 25th April 2022 will be approximately £39.6 million (€47.1 million) reflecting a further fair value increase of £11.1 million since 31 December 2021."
Started: unhooked, 21 Apr 2022 21:10
Last post: unhooked, 23 Apr 2022 12:02
That sounds like good management.
Hi unhooked,
I sold those at a loss following the ukraine invasion
I actually sold down all but one of my investments, some at a loss, but as a whole with a profit.
I have been picking up a few bargain shares (as I see them) and feel that SUPP may be one.
I have no hesitation making small losses and am playing everything short term for the time being.
NoQuestion - you say you bought shares for 29p on 26th January and now you're "putting toe back in the water again". Adopting a short-term trading approach to SUPP may well serve you better than a long-term investment approach has served me.
I'm delighted that the fund is looking to invest outside of the UK, I will certainly be voting in favour.
A rename to the Schroders International Public Private seems an obvious move (SIPP)
They are also seeking to renew the authority to buyback up to 14.99% of the stock, again I'll be voting in favour.
I am puzzled that, to the best of my knowledge, they have not bought back a single share despite the share price being in the mid 20s with the NAV in the high 30s.
Is it any wonder that the market questions the accuracy of the NAV.
I welcomed the public investments into Spirent and Johnson Matthey but not the timing of the buys, we are currently underwater on both.
I'm putting toe back in the water again in the hope that it is upwards from here.
They can't get their UK investments to work, so now they want to go global.
They say they're 'frustrated' by the share price and 'focussed' on the discount to NAV, but they're not doing anything to fix it.
It's all waffle really.
Started: pasajerodeltoro, 4 Apr 2022 12:12
Last post: pasajerodeltoro, 4 Apr 2022 12:12
Started: pasajerodeltoro, 18 Mar 2022 20:18
Last post: pasajerodeltoro, 4 Apr 2022 11:54
"on ne saurait faire d’omelette sans casser des œufs"
pasajero teaching us all how to suck eggs.
I sent the US State Department a message.
Go to: tinyurl.com
put in url-query: "/yd959wdt"
#reactionengines
This is a long term investment. There are some advantages in holding a investment trust over an OEIC.
"An investment trust’s share price is dependent on two key factors: the performance of the underlying assets, and supply and demand for the shares. At any particular time, the shares could be trading at a discount to the value of the underlying assets (where investor demand is low), or at a premium (where investor demand is high)."
- janushenderson website: archive.ph/m1Nra#selection-1261.0-1261.331
A hypersonic conveyance is required for SUPP, which is completely stuck - now for 2 years - in the 'forgotten' park. Disastrous investment.
Started: pasajerodeltoro, 31 Mar 2022 19:11
Last post: pasajerodeltoro, 31 Mar 2022 19:11
Started: Whathappen1, 21 Mar 2022 21:08
Last post: Whathappen1, 21 Mar 2022 21:08
ONT final statement tomorrow. SP highs 716 and lows 369 in 3 months. If good news, this could move back towards NAV, fingers crossed.
Started: beardozer, 4 Mar 2022 14:46
Last post: pasajerodeltoro, 18 Mar 2022 20:07
Russia launches 7,000mph Zircon hypersonic nuke missile, The Sun, Mar 14 2022
https://youtu.be/YZW8oMo8Irk
https://www.express.co.uk/news/world/1582397/vladmir-putin-nuclear-weapons-russia-ukraine-world-war-three
https://pastebin.com/2xFpP2Z2
"Where could Russia target?
A missile strike by Russia on London would not be Vladimir Putin’s primary goal should the UK and other nations be dragged into the war in Ukraine, a senior defence official has told i.
The official, who requested anonymity, said Putin would “strike London for its symbolic impact” but would also prioritise Britain’s nuclear submarine fleet and its three main naval bases in Clyde, Devonport and Portsmouth.
“A strike, whether using conventional or nuclear missiles, would almost certainly occur in London should Putin push on with his threats against the West,” said the source. “However, while that would create the pictures around the world Putin would want, he would be more concerned with hitting our nuclear submarines, three of which can be in or around any of the UK’s main naval bases.” "
3.7% of their holdings are in Reaction Engines and they've recently made a-lot of money from the Oxford Nanopore IPO. I'd expect them to increase their holdings here and I think it's very likely the MOD will get the govt to allocate their defence budget to this sector thanks to Putin's unhinged nuclear threats.
https://imgur.com/a/6TQ3SAf
Look up "Reaction engines". Might get a surprise increase in the NAV for this in the near future from the MOD given what's been happening in Ukraine.